Epogee produces a portfolio of fat replacement and flavor enhancement food ingredients using patented technologies. The company’s products are Kosher, gluten free, allergen free, vegan, and made from natural vegetable oils free from genetically modified materials. Epogee has achieved FDA GRAS status for use across confectionery, frying, baked goods and baking mixes, frozen desserts and mixes, nut products including peanut butter, grain products, pasta, granola and snack bars, sauces and gravies, and soft candy. The company is led by CEO John Musselman. Epogee raised $8.3M in funding and intends to use the proceeds to expand current manufacturing and accelerate technical capabilities to support customers.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2019